Literature DB >> 30835972

Advanced heart failure: A review.

Klementyna Kępińska1, Daria Maria Adamczak2, Marta Kałużna-Oleksy2.   

Abstract

Heart failure (HF) has been recognized as a pandemic and is a serious clinical and health problem associated with significant mortality, morbidity and expenditure on healthcare, especially among older people. Progress in medicine has made it possible for an increasing number of people with HF to live longer than ever before. Therefore, a new and serious clinical problem has appeared - advanced heart failure (AHF). A better understanding of this issue is very important, because there are many more patients waiting for transplantations than there are available hearts. The role of the medical team is to keep the patient in the best condition until the heart transplant/implantation of left ventricular assist devices or at least to ensure the best possible quality of life. This article reviews the available data on AHF. The authors have succinctly presented different definitions and methods of the AHF diagnosis established by medical societies, as well as epidemiological data, methods of assessment, and possible treatment strategies.

Entities:  

Keywords:  advanced heart failure; decompensation; heart failure; stage D

Mesh:

Year:  2019        PMID: 30835972     DOI: 10.17219/acem/103669

Source DB:  PubMed          Journal:  Adv Clin Exp Med        ISSN: 1899-5276            Impact factor:   1.727


  5 in total

1.  Sacubitril/Valsartan for heart failure: A protocol for systematic review and meta-analysis.

Authors:  Wenqin Dai; Jinlan Luo; Xianli Huang
Journal:  Medicine (Baltimore)       Date:  2022-06-10       Impact factor: 1.817

2.  The discrepancies between clinical and histopathological diagnoses of cardiomyopathies in patients with stage D heart failure undergoing heart transplantation.

Authors:  Thana Lertsuttimetta; Monravee Tumkosit; Peerapat Kaveevorayan; Poonchavist Chantranuwatana; Nonthikorn Theerasuwipakorn; Pairoj Chattranukulchai; Sarinya Puwanant
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

3.  Remuscularization with triiodothyronine and β1-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling.

Authors:  Nikolay Bogush; Lin Tan; Emmen Naqvi; John W Calvert; Robert M Graham; W Robert Taylor; Nawazish Naqvi; Ahsan Husain
Journal:  Sci Rep       Date:  2022-05-25       Impact factor: 4.996

4.  Association between self-management behaviour and quality of life in people with heart failure: a retrospective study.

Authors:  Eui-Young Choi; Jin-Sun Park; Deulle Min; Hye Sun Lee; Jeong-Ah Ahn
Journal:  BMC Cardiovasc Disord       Date:  2022-03-08       Impact factor: 2.298

Review 5.  Nanomaterials for Cardiac Tissue Engineering.

Authors:  Devang R Amin; Eric Sink; Suguna P Narayan; Mostafa Abdel-Hafiz; Luisa Mestroni; Brisa Peña
Journal:  Molecules       Date:  2020-11-07       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.